Neuronetics (STIM) Return on Capital Employed (2018 - 2026)
Neuronetics (STIM) posted quarterly Return on Capital Employed of 27.96% for Q1 2026, up 525.0% year-over-year from 4.47% in Q1 2025, and little changed quarter-over-quarter from 27.82% in Q4 2025.
Neuronetics (STIM) Return on Capital Employed (2018 - 2026) Analysis & Trends
Neuronetics (STIM) has reported Return on Capital Employed for 9 consecutive years, with 27.96% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed rose 525.0% year-over-year to 27.96%; the TTM figure through Mar 2026 stood at 27.96% (up 525.0% YoY), while the FY2025 annual figure was 28.4%, up 720.0% from the prior year.
- Return on Capital Employed steadied at 27.96% in Q1 2026 per STIM's latest filing, from 27.82% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 25.16% in Q1 2022 and bottomed at 45.34% in Q4 2024.
- Historically, Return on Capital Employed has averaged 35.18% across 5 years, with a median of 35.74% in 2022.
- Annual changes were most pronounced in 2022 — Return on Capital Employed tumbled 1958 bps — and 2025, when it jumped 1751 bps.
- Neuronetics' Return on Capital Employed stood at 41.38% in 2022, then climbed by 13 bps to 36.12% in 2023, then retreated by 26 bps to 45.34% in 2024, then surged by 39 bps to 27.82% in 2025, then declined by 0 bps to 27.96% in 2026.
- Business Quant data shows STIM's Return on Capital Employed at 27.96% in Q1 2026, 27.82% in Q4 2025, and 34.08% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.08% |
| 10 | Neuronetics | 225.97 Mn | 206.54 Mn | 21.22 Mn | -22.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22.82% |
| Mar 31, 2026 | -27.96% |
| Dec 31, 2025 | -27.82% |
| Sep 30, 2025 | -34.08% |
| Jun 30, 2025 | -34.63% |
| Mar 31, 2025 | -33.21% |
| Dec 31, 2024 | -45.34% |
| Sep 30, 2024 | -40.14% |
| Jun 30, 2024 | -40.34% |
| Mar 31, 2024 | -28.86% |
| Dec 31, 2023 | -36.12% |
| Sep 30, 2023 | -41.61% |
| Jun 30, 2023 | -37.30% |
| Mar 31, 2023 | -36.68% |
| Dec 31, 2022 | -41.38% |
| Sep 30, 2022 | -35.74% |
| Jun 30, 2022 | -31.64% |
| Mar 31, 2022 | -25.16% |
| Dec 31, 2021 | -21.80% |
| Sep 30, 2021 | -23.85% |